Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

Por Munzone, Elisabetta, Curigliano, Giuseppe, Rocca, Andrea, Bonizzi, Giuseppina, Renne, Giuseppe, Goldhirsch, Aron, Nolè, Franco
Publicado em 2006

Correction: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

Por Munzone, Elisabetta, Curigliano, Giuseppe, Rocca, Andrea, Bonizzi, Giuseppina, Renne, Giuseppe, Goldhirsch, Aron, Nolè, Franco
Publicado em 2006

Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study

Por Montemurro, Filippo, Redana, Stefania, Nolè, Franco, Donadio, Michela, Jacomuzzzi, Maria Elena, Valabrega, Giorgio, Viale, Giuseppe, Sapino, Anna, Aglietta, Massimo
Publicado em 2008

Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison

Por Redana, Stefania, Donadio, Michela, Nolè, Franco, Jacomuzzi, Maria Elena, Beano, Alessandra, Martinello, Rossella, Sapino, Anna, Viale, Giuseppe, Aglietta, Massimo, Montemurro, Filippo
Publicado em 2010

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma

Por Petralia Giuseppe, Fodor Cristiana, Petazzi Elena, Santoro Luigi, Leonardi Maria C, Magni Elena, Zampino Maria G, Trovato Cristina, Nolè Franco, Orecchia Roberto
Publicado em 2011-02-01

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma

Por Zampino, Maria G, Magni, Elena, Leonardi, Maria C, Santoro, Luigi, Petazzi, Elena, Fodor, Cristiana, Petralia, Giuseppe, Trovato, Cristina, Nolè, Franco, Orecchia, Roberto
Publicado em 2011

Underuse of Anthracyclines in Women with HER-2(+) Advanced Breast Cancer

Por Montemurro, Filippo, Rossi, Valentina, Nolè, Franco, Redana, Stefania, Donadio, Michela, Martinello, Rossella, Verri, Elena, Valabrega, Giorgio, Rocca, Maria Cossu, Jacomuzzi, Maria Elena, Viale, Giuseppe, Sapino, Anna, Aglietta, Massimo
Publicado em 2010

Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience

Por Gerardi, Marianna A., Jereczek-Fossa, Barbara A., Zerini, Dario, Surgo, Alessia, Dicuonzo, Samantha, Spoto, Ruggero, Fodor, Cristiana, Verri, Elena, Rocca, Maria Cossu, Nolè, Franco, Muto, Matteo, Ferro, Matteo, Musi, Gennaro, Bottero, Danilo, Matei, Deliu V., De Cobelli, Ottavio, Orecchia, Roberto
Publicado no Ecancermedicalscience (2016)

Dual modulation of MCL-1 and mTOR determines the response to sunitinib

Por Elgendy, Mohamed, Abdel-Aziz, Amal Kamal, Renne, Salvatore Lorenzo, Bornaghi, Viviana, Procopio, Giuseppe, Colecchia, Maurizio, Kanesvaran, Ravindran, Toh, Chee Keong, Bossi, Daniela, Pallavicini, Isabella, Perez-Gracia, Jose Luis, Lozano, Maria Dolores, Giandomenico, Valeria, Mercurio, Ciro, Lanfrancone, Luisa, Fazio, Nicola, Nole, Franco, Teh, Bin Tean, Renne, Giuseppe, Minucci, Saverio
Publicado no J Clin Invest (2016)